C
Caris Life Sciences Inc
NASDAQ:CAI
Caris Life Sciences Inc
NASDAQ:CAI
Price:
20.52
USD
-8.6%
Market Closed
Market Cap:
$5.8B
Cash Flow Statement
Cash Flow Statement
Caris Life Sciences Inc
Caris Life Sciences Inc
Currency:
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
(345)
|
(321)
|
|
| Depreciation & Amortization |
45
|
50
|
|
| Stock-Based Compensation |
43
|
57
|
|
| Other Non-Cash Items |
121
|
140
|
|
| Change in Working Capital |
(16)
|
(2)
|
|
| Cash from Operating Activities |
(195)
N/A
|
(133)
+32%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(11)
|
(18)
|
|
| Other Items |
0
|
0
|
|
| Cash from Investing Activities |
(11)
N/A
|
(18)
-66%
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
664
|
665
|
|
| Net Issuance of Debt |
24
|
24
|
|
| Other |
(5)
|
(27)
|
|
| Cash from Financing Activities |
683
N/A
|
662
-3%
|
|
| Change in Cash | |||
| Effect of Foreign Exchange Rates |
0
|
0
|
|
| Net Change in Cash |
477
N/A
|
511
+7%
|
|
| Free Cash Flow | |||
| Free Cash Flow |
(206)
N/A
|
(151)
+27%
|
|
Switch to:
Switch to:
See Also
Discover More
